Loading company…
Resistell AG, based in Basel, develops rapid antibiotic susceptibility testing using nanomotion technology.
Founded in 2018 in Basel, Switzerland, Resistell AG makes the Phenotech platform, which detects nanoscale vibrations from living bacteria to test antibiotic sensitivity in hours instead of days. It sells to hospitals and diagnostic laboratories through purchases or subscriptions. In December 2022 it raised CHF 8.5 million in Series B funding, with participation from the European Innovation Council, Occident Group, TRUMPF Venture, Zürcher Kantonalbank, and bp Launchpad.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in